Defining Objective Markers of Compliance for Dietary Therapies in IBS
This study is looking for a way to objectively measure how well people with Irritable Bowel Syndrome (IBS) follow certain diets. Researchers want to see if a specific marker in your stool, called GIP (Gluten immunogenic Peptides), can show how much of certain carbohydrates, like fructo-oligosaccharides, you're eating. You would be assigned to either Diet A, which limits certain carbohydrates, or Diet B, a healthy eating diet. The study aims to see if GIP levels in your stool correlate with your carbohydrate intake after four weeks. This could help doctors better understand how diet affects IBS. The study is open to adults aged 18 to 65 who have IBS.
- Study design
- This is an interventional study planning to enroll 94 participants. You would be assigned to one of two behavioral diets.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint is measured at Week 4, suggesting a follow-up period of at least four weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Defining Objective Markers of Compliance for Dietary Therapies in IBS
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Prashant Singh, MBBS · PRINCIPAL_INVESTIGATOR · University of Michigan
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Correlation between fecal GIP excretion and fructo-oligosaccharide intakeWeek 4
Assessed using 24-hour recall